Blue Wolf Capital Partners has acquired a majority stake in North American Rescue (NAR), a supplier of tactical medical products. NAR’s Chief Executive Officer, Bob Castellani, and other members of the NAR management team invested alongside Blue Wolf and will remain in their current positions.
“We are excited to invest alongside Bob and management in NAR and we are eager to execute on the company’s organic growth and acquisition opportunities,” said Michael Ranson, Partner at Blue Wolf. “Operating in a market that serves our country’s national interests, the company has established itself as a leading player with a strong competitive position and products of the highest quality that are mission-critical in saving lives. “
NAR’s tactical medical products include tourniquets, chest seals and decompression needles and are sold to military, federal agency, civilian law enforcement, and EMS customers. NAR designs, develops and tests these products based on the military’s Tactical Combat Casualty Care (TCCC) guidelines, Rescue Human Factors engineering, evidence-based medicine and an in-depth understanding of the requirements of its customers. Within its employee group, NAR has assembled a staff of former Special Operations medics, experienced Law Enforcement / SWAT / EMS healthcare providers, credentialed product development and quality professionals, former senior military medical officers and expert consultants. NAR was founded in 1996 and is headquartered in Greenville, SC (www.narescue.com).
Blue Wolf invests in companies in which effective management of relationships with complex constituencies, such as government and labor, can change organizations and create value. The firm’s investment criteria are minimum revenues of $25 million; minimum transaction size of $20 million; and a minimum investment size of $10 million. The firm focuses its efforts on companies based in the United States and Canada. Blue Wolf has $460 million of capital under management and is headquartered in New York (www.blue-wolf.com).
“Blue Wolf’s relationships within the defense and medical industry will create additional growth opportunities for NAR,” said CEO Bob Castellani. “Their track record of using strategic acquisitions to grow their portfolio companies will prove valuable as we seek to expand the company’s product offering and better serve the requirements of our customers.”
“The NAR transaction touches on several areas of Blue Wolf’s investment focus. We have a long history of successfully partnering with existing management teams. In addition, we have a strong track record of investing in middle market defense and healthcare businesses, and we plan to deploy meaningful capital in those sectors in the future,” said Adam Blumenthal, Managing Partner at Blue Wolf.
Arlington, VA –based Renaissance Strategic Advisors (www.rsadvisors.com) and Holland & Knight (www.hklaw.com ) provided advisory services to Blue Wolf on this transaction.
© 2015 PEPD • Private Equity’s Leading News Magazine •3-2-15
